Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Mar 30, 2017 · 10-K · 89 days after period end · 0001493152-17-002998
derived · Computed from the longer spans the company filed.
| Metric | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$4.70M | -$7.98M | -$1.06M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 30, 2017 · 89 d after period end
